Crowd Media to assist leading UK-based consumer products business
Crowd Media Holdings Limited (ASX:CM8 | FWB:CM3) has executed an exclusive and binding Marketing Services Agreement with London-based VITAL Innovations Ltd to market and sell key VITAL portfolio brands and products into the European market, excluding the UK.
This arrangement will leverage Crowd’s core strengths across the digital marketing, direct-to-consumer digital commerce, social media, influencer marketing and social commerce disciplines, driving web and mobile sales of VITAL products across Europe, enabling VITAL to roll out its award-winning brands into European Union markets.
Founded 40 years ago, VITAL is a UK-domiciled family-owned business that has created and launched a number of successful brands across a number of sectors including healthcare, consumer and water purification sectors.
The VITAL portfolio of brands includes Vital Baby, Vital Family & Super Safe.
Crowd and VITAL’s exclusive Marketing Service Agreement or what can also be termed as a European Union-based social media, influencer marketing and social commerce partnership will include the promotion and sale on a Direct to Consumer (D2C) model of some of VITAL’s brands into EU markets, while also developing and executing on all-encompassing digital marketing campaigns across Europe.
With regard to the financial implications of the proposed agreement, revenue share payments shall be payable on net sales generated for Vital Products sold as a result of Crowd’s marketing services as well as all sales generated through various websites controlled by Vital, regardless of whether such sales occur during or after the term of two years.
Crowd will be receiving 100% of Net Sales, or as agreed on a product-by-product basis.
Agreement draws on Crowd’s regional and demographic experience
This intended collaboration marks another milestone in the execution of the Crowd Media’s strategic vision as outlined by the company’s chairman Steven Schapera at the November 2019 AGM, when he highlighted the group’s plan to sell exemplary products integral to the lives of European-based millennials on a direct-to-consumer model.
Crowd has deep experience in digital marketing to millennials in most European countries across 12 different languages, and the company will be using influencer and performance marketing strategies to drive VITAL sales.
Underlining the complementary characteristics between the two parties, Crowd chief executive Domenic Carosa said, “We are pleased to have executed an exclusive agreement with VITAL.
‘’They are a powerful, family-owned company and have been in business more than 40 years.
‘’Their portfolio brands are of special interest to Crowd because their target customer is almost always a millennial, perfectly matched to our social media and influencer marketing skills.
‘’We have already identified a number of VITAL key products and market segments in the healthcare and consumer space where we will focus our initial efforts.
‘’Crowd can really add value here, leveraging our five years of social media, social influencer and social commerce experience for the benefit of both parties.”
VITAL has agreed to subscribe for 5 million Crowd Media Holding Ltd shares at 3 cents per share, raising a total of $150,000 for general working capital purposes, further cementing the relationship between the parties.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.